Healthcare -
Biotechnology - NASDAQ - NL
$ 2.17
0.93 %
$ 224 M
Market Cap
-7.0
P/E
Price Target
Average
56.68%
Revenue Forecast
Estimate
150.10%
EBIT
Estimate
--24.27%
Net Income
Estimate
16.77%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
ProQR Therapeutics N.V.
Wall Street analysts predict an average 1-year price target for PRQR of $3.4 , with forecasts ranging from
a
low of
$2 to a high of $5 .
PRQR Lowest Price Target
Wall Street Target
2 USD
-7.83%
PRQR Average Price Target
Wall Street Target
3.4 USD
56.68%
PRQR Highest Price Target
Wall Street Target
5 USD
130.41%
REVENUE FORECAST
Revenue Forecast Chart PRQR
EBIT FORECAST
EBIT Forecast Chart PRQR
NET INCOME FORECAST
Net Income Chart PRQR